A bill to amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.
About This Bill
Committee
Latest Action · December 11, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.